Skip to content

Health

FDA Approves Moderna's First mRNA Flu Vaccine

FDA Approves Moderna's First mRNA Flu Vaccine

In a clinical study involving 40,000 adults aged 50 to 64, Moderna's vaccine reduced influenza cases by approximately 27 percent. The FDA also granted accelerated approval for adults aged 65 and older.

Members Public